Influx Healthtech Q4 Results
- BSE: -
- NSE: INFLUX
- ISIN: INE0MYZ01012
- Sector: Biotechnology & Drugs
BSE
This stock is not traded on BSE
NSE
271.00
-3.80 (-1.38%)
-3.80 (-1.38%)Volume8.40 K
Updated: Fri 11 Sep, 2026 | 15:28:40
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹80.07 Cr.-
- Operating Profit₹13.10 Cr.-
- Profit After Tax₹10.53 Cr.-
- Operating Margin16.36%(NA%)
Note: Comparison is on YoY basis
Quarterly - Influx Healthtech Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | - | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 66.97 | - | N/A |
| Depreciation/ Amortization | 2.09 | - | N/A |
| Operating Income | 13.10 | - | N/A |
| Net Income | 10.53 | - | N/A |
| Other Operating Expenses Total | 9.06 | - | N/A |
| Net Income Before Taxes | 14.16 | - | N/A |
| Total Revenue | 80.07 | - | N/A |
| Selling/ General/ Admin Expenses Total | 6.67 | - | N/A |
| Diluted Normalized EPS | 5.06 | - | N/A |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.